Xiao-kun Zhang Selected Research

Xiao-kun Zhang Research Topics

Disease

14	Neoplasms (Cancer) 01/2015 - 05/2002
3	Lung Neoplasms (Lung Cancer) 12/2003 - 05/2002
2	Leukemia 10/2006 - 11/2003
2	Acute Promyelocytic Leukemia 10/2006 - 11/2003
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2015
1	Inflammation (Inflammations) 01/2015
1	Rupture 10/2012
1	Atherosclerotic Plaque (Atheroma) 10/2012
1	Thrombosis (Thrombus) 10/2012
1	Renovascular Hypertension (Goldblatt Syndrome) 10/2012
1	Neoplasm Metastasis (Metastasis) 02/2005
1	Adenocarcinoma 02/2005
1	Prostatic Neoplasms (Prostate Cancer) 02/2005
1	B-Cell Leukemia (Leukemia, B Cell) 11/2003
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2003
1	Breast Neoplasms (Breast Cancer) 07/2003
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2002
1	Esophageal Neoplasms (Esophageal Cancer) 01/2002
1	Carcinogenesis 01/2002

Drug/Important Bio-Agent (IBA)

6	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2006 - 01/2002
5	Proteins (Proteins, Gene)FDA Link 11/2008 - 02/2004
3	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2015 - 02/2005
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2015 - 02/2004
3	LigandsIBA 01/2015 - 07/2003
3	Transcription Factors (Transcription Factor)IBA 11/2010 - 06/2002
3	RetinoidsIBA 11/2003 - 05/2002
3	retinoic acid receptor betaIBA 07/2003 - 01/2002
3	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 07/2003 - 01/2002
2	CD 437IBA 01/2007 - 11/2003
2	OvalbuminIBA 07/2003 - 06/2002
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2015
1	Bexarotene (LGD1069)FDA Link 01/2015
1	Sulindac (Copal)FDA LinkGeneric 05/2014
1	calpain inhibitorsIBA 06/2013
1	IonomycinIBA 06/2013
1	CalpainIBA 06/2013
1	ApolipoproteinsIBA 10/2012
1	Phenobarbital (Luminal)FDA Link 10/2012
1	XenobioticsIBA 01/2012
1	triptolideIBA 01/2012
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2012
1	Cytochromes c (Cytochrome c)IBA 09/2011
1	Oncogene Proteins (Oncogene Protein)IBA 11/2010
1	shikoninIBA 11/2008
1	Peptides (Polypeptides)IBA 10/2008
1	Amino Acids FDA Link 10/2008
1	4-O-carboxymethylascochlorinIBA 01/2007
1	Carboxylic AcidsIBA 01/2007
1	naphthaleneIBA 01/2007
1	Retinoic Acid Receptor alphaIBA 10/2006
1	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 10/2006
1	Cyclin-Dependent Kinase-Activating KinaseIBA 10/2006
1	Etodolac (Lodine)FDA LinkGeneric 02/2005
1	Orphan Nuclear ReceptorsIBA 02/2004
1	Antineoplastic Agents (Antineoplastics)IBA 02/2004
1	Bromodeoxyuridine (BrdU)IBA 12/2003
1	Small Interfering RNA (siRNA)IBA 12/2003
1	Epidermal Growth Factor (EGF)IBA 12/2003
1	bcl-X ProteinIBA 11/2003
1	AcidsIBA 11/2003
1	4- (3- (1- adamantyl)- 4- hydroxyphenyl)- 3- chlorocinnamic acidIBA 11/2003
1	PPAR gammaIBA 07/2003
1	ciglitazoneIBA 07/2003
1	Histone Deacetylase InhibitorsIBA 07/2003
1	SR 11237IBA 07/2003
1	trichostatin A (A 300)IBA 07/2003
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 06/2002
1	Nicotine FDA Link 05/2002
1	Vitamin A (Retinol)FDA LinkGeneric 05/2002
1	Antisense RNA (Anti-Sense RNA)IBA 05/2002
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2002
1	Messenger RNA (mRNA)IBA 01/2002

Therapy/Procedure

1	Ligation 10/2012
1	Therapeutics 01/2012
1	Chemoprevention 02/2005